SMTL ID : 6v5l.1

The HADDOCK structure model of GDP KRas in complex with its allosteric inhibitor E22

Coordinates

PDB Format

Method

SOLUTION NMR

Oligo State

monomer

Ligands

1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)

GDP.1: 22 residues within 4Å: Chain A: G.12, G.13, V.14, G.15, K.16, S.17, A.18, F.28, V.29, D.30, E.31, Y.32, P.34, D.57, N.116, K.117, D.119, L.120, S.145, A.146, K.147 Ligands: MG.2 16 PLIP interactions: 16 interactions with chain A Hydrogen bonds: A:G.13, A:V.14, A:G.15, A:K.16, A:S.17, A:S.17, A:S.17, A:A.18, A:N.116, A:K.117, A:S.145, A:A.146, A:K.147 Salt bridges: A:D.119 pi-Stacking: A:F.28, A:F.28

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 6 residues within 4Å: Chain A: K.16, S.17, I.36, D.57, T.58 Ligands: GDP.1 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:S.17, A:D.57, A:D.57

1 x QPD: (2R)-2-[2-(1H-indole-3-carbonyl)hydrazinyl]-2-phenylacetamide(Non-covalent)

QPD.3: 14 residues within 4Å: Chain A: K.5, L.6, V.7, E.37, S.39, R.41, D.54, I.55, L.56, M.67, Q.70, Y.71, T.74, G.75 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:K.5, A:V.7, A:L.56, A:Y.71, A:Y.71 Hydrogen bonds: A:E.37, A:E.37, A:I.55, A:Q.70 pi-Cation interactions: A:K.5, A:K.5

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gupta, A.K. et al., Multi target ensemble based virtual screening yields novel allosteric KRAS inhibitors at high success rate. Chemical Biology & Drug Design (2019)

Release Date

2019-12-18

Peptides

GTPase KRas: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

GTPase KRas

Related Entries With Identical Sequence